Astrazeneca to begin Phase 1/2 clinical trials of coronavirus vaccine in Japan

Astrazeneca to begin Phase 1/2 clinical trials of coronavirus vaccine in Japan Trials of the vaccine, known as AZD1222, will be conducted at multiple facilities in Japan, targeting 250 subjects, the company said in a release. https://ift.tt/eA8V8J